Doxazosin EP Impurity C CAS 617677-53-9
| CAS No. | 617677-53-9 |
| Molecular Formula | C22H22N2O6 |
| Molecular Weight | 410.42 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Doxazosin EP Impurity C.
As a process- or degradation-related impurity, Doxazosin EP Impurity C (CAS 617677-53-9, C22H22N2O6) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Owing to a flavonoid core, an amide group, a hydroxyl group, an ether linkage, Doxazosin EP Impurity C is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 410.42 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C22H22N2O6 |
| Molecular Weight | 410.42 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1985 |
| Nitrogen Atoms | 2 |
Related Doxazosin Standards
Recommended Standards
- Rivaroxaban Impurity 121 (CAS 1855920-51-2)
- Irinotecan Impurity 54 (CAS 142677-15-4)
- 84633-28-3 Eurycomanol Picrasa-3,13(21)-dien-16-one, 11,20-epoxy-1,2,11,12,14,15-hexahydroxy-, (1beta,2alpha,11beta,12alpha,15beta)- (1beta,2alpha,11beta,12alpha,15beta)-11,20-Epoxy-1,2,11,12,14,15-hexahydroxypicrasa-3,13(21)-dien-16-one (CAS 84633-28-3)
- benzhydryl (7R)-7-amino-3-(chloromethyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS CATO-C4X-179854)
- Dextromethorphan Impurity 16 HCl (CAS 30356-07-1(free base))
- Bisoprolol Impurity 62 Formate (CAS 109791-18-6(free base))
- Dapagliflozin Impurity 63 (CAS 2768435-31-8)
- 5-((4-Chlorophenyl)sulfinyl)-N-ethyl-1,2,3-thiadiazole-4-carboxamide (CAS 306977-05-9)
- (S)-3-azaspiro[5.5]Undecan-7-amine dihydrochloride (CAS 2306249-45-4)
- (E)-Hex-4-en-1-amine (CAS 55108-01-5)
- 6108-23-2 ZQS5S890B6 Lithium formate monohydrate UNII-ZQS5S890B6 Formic acid, lithium salt, monohydrate Lithium formate monohydrate [MI] Monolithium formate monohydrate (CAS 6108-23-2)
- (S)-4-(2,4-Dimethoxybenzyl)-3-methylpiperazin-2-one hydrochloride (CAS 2007940-85-2)
- N-(2-(2-Butyl-1H-indol-3-yl)ethyl)acetamide (CAS 823821-84-7)
- Semaglutide impurity 250 (CAS CATO-C4X-2226250)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com